Uncategorized
Imprimis reports 195% revenue increase in second quarter
Imprimis Pharmaceuticals reported total revenue of $2 million in the second quarter, a 195% increase from $0.7 million in the same quarter of 2014, according to a press release. Net loss was reported at $3.7 million, or $0.39 per share, in the second quarter compared with a net loss of $2.6 million, or $0.28 per share, in the same quarter of 2014.